Vimarsana
Biggest News Aggregation in the World

Page 4 - Visual Acuity News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Visual Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Visual Acuity Today - Breaking & Trending Today

Does supplementation with omega-3, and -6 fatty acids to extremely preterm infants improve visual acuity? - Vimarsana News

Does supplementation with omega-3, and -6 fatty acids to extremely preterm infants improve visual acuity?

Sweden: A follow-up of a randomized controlled trial revealed that postnatal supplementation with enteral polyunsaturated fatty acids in extremely preterm children leads to better visual function by...

Biosimilars Comparable to Aflibercept in Macular Disease - Vimarsana News

Biosimilars Comparable to Aflibercept in Macular Disease

Phase 3 registration trials found the comparability of two biosimilars to reference aflibercept in terms of efficacy, safety, pharmacokinetics, and immunogenicity.

Study Shows Vision, Anatomy Stable With Port System for AMD - Vimarsana News

Study Shows Vision, Anatomy Stable With Port System for AMD

Recalled in 2022, a port delivery system for ranibizumab to treat wet AMD demonstrated that vision and retinal anatomy remained stable in patients who had the device for 5 years.

Vision problems could mean higher dementia risk, study finds: 'Eye health and brain health are closely linked' - Vimarsana News

Vision problems could mean higher dementia risk, study finds: 'Eye health and brain health are closely linked'

Older adults with vision problems may be more likely to develop dementia, a new study published in JAMA Ophthalmology found. Experts reveal the link between eye health and brain health.

Source: yahoo.com
Gene Therapy Promising for Hereditary Vision Loss - Vimarsana News

Gene Therapy Promising for Hereditary Vision Loss

Patients with a progressive form of Leber hereditary optic neuropathy (LHON) that causes rapid vision loss experienced improvement in their eyesight with an experimental gene therapy.